271 related articles for article (PubMed ID: 24655067)
21. Mesenchymal stem cell-derived exosomes: A novel potential therapeutic avenue for cardiac regeneration.
Safari S; Malekvandfard F; Babashah S; Alizadehasl A; Sadeghizadeh M; Motavaf M
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):66-73. PubMed ID: 27453275
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
Gu Z; Cao X; Jiang J; Li L; Da Z; Liu H; Cheng C
Cell Signal; 2012 Dec; 24(12):2307-14. PubMed ID: 22820504
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cell treatment for autoimmune diseases: a critical review.
Figueroa FE; Carrión F; Villanueva S; Khoury M
Biol Res; 2012; 45(3):269-77. PubMed ID: 23283436
[TBL] [Abstract][Full Text] [Related]
24. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation.
Choi EW; Shin IS; Park SY; Park JH; Kim JS; Yoon EJ; Kang SK; Ra JC; Hong SH
Arthritis Rheum; 2012 Jan; 64(1):243-53. PubMed ID: 21904997
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis.
Wang X; Gu H; Qin D; Yang L; Huang W; Essandoh K; Wang Y; Caldwell CC; Peng T; Zingarelli B; Fan GC
Sci Rep; 2015 Sep; 5():13721. PubMed ID: 26348153
[TBL] [Abstract][Full Text] [Related]
26. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.
Liang X; Ding Y; Zhang Y; Tse HF; Lian Q
Cell Transplant; 2014; 23(9):1045-59. PubMed ID: 23676629
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions.
Lee BW; Kwok SK
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373308
[TBL] [Abstract][Full Text] [Related]
29. Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy.
Rosca AM; Rayia DM; Tutuianu R
Curr Stem Cell Res Ther; 2017; 12(2):134-138. PubMed ID: 26496883
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration.
Nakamura Y; Miyaki S; Ishitobi H; Matsuyama S; Nakasa T; Kamei N; Akimoto T; Higashi Y; Ochi M
FEBS Lett; 2015 May; 589(11):1257-65. PubMed ID: 25862500
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
[TBL] [Abstract][Full Text] [Related]
32. Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus.
Perez-Hernandez J; Redon J; Cortes R
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350323
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
Wang J; Liao L; Tan J
Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
[TBL] [Abstract][Full Text] [Related]
34. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
Sun L; Wang D; Liang J; Zhang H; Feng X; Wang H; Hua B; Liu B; Ye S; Hu X; Xu W; Zeng X; Hou Y; Gilkeson GS; Silver RM; Lu L; Shi S
Arthritis Rheum; 2010 Aug; 62(8):2467-75. PubMed ID: 20506343
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.
Rani S; Ryan AE; Griffin MD; Ritter T
Mol Ther; 2015 May; 23(5):812-823. PubMed ID: 25868399
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stromal cells and rheumatic disorders.
Tyndall A
Immunol Lett; 2015 Dec; 168(2):201-7. PubMed ID: 26142543
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
Front Immunol; 2021; 12():728190. PubMed ID: 34659214
[TBL] [Abstract][Full Text] [Related]
38. Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect.
Kusuma GD; Carthew J; Lim R; Frith JE
Stem Cells Dev; 2017 May; 26(9):617-631. PubMed ID: 28186467
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.
Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW
Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine.
Motavaf M; Pakravan K; Babashah S; Malekvandfard F; Masoumi M; Sadeghizadeh M
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):74-9. PubMed ID: 27453276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
